M&T Bank Corp Astrazeneca PLC Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, M&T Bank Corp holds 267,830 shares of AZN stock, worth $20.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

267,830

Previous 249,836 7.2%

Holding current value

$20.8 Million

Previous $16.9 Million 23.41%

% of portfolio

0.07%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$66.81 - $80.83 $1.2 Million - $1.45 Million	17,994 Added 7.2%	267,830 $20.9 Million
Q1 2024 May 07, 2024	SELL	$61.03 - $69.57 $1.6 Million - $1.83 Million	-26,274 Reduced 9.52%	249,836 $16.9 Million
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $691,806 - $774,411	-11,178 Reduced 3.89%	276,110 $18.6 Million
Q3 2023 Nov 02, 2023	BUY	$64.85 - $71.7 $309,593 - $342,295	4,774 Added 1.69%	287,288 $19.5 Million
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $429,247 - $465,473	-6,140 Reduced 2.13%	282,514 $20.2 Million
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $532,101 - $603,301	-8,426 Reduced 2.84%	288,654 $20 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $616,096 - $800,550	-11,365 Reduced 3.88%	281,795 $19.1 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $828,599 - $1.08 Million	15,285 Added 5.42%	297,080 $20.1 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $4.93 Million - $12.6 Million	92,938 Added 46.42%	293,160 $16.1 Million
Q2 2022 Aug 05, 2022	BUY	$59.26 - $71.14 $412,271 - $494,920	6,957 Added 3.6%	200,222 $12.8 Million
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $664,962 - $801,010	-11,934 Reduced 5.82%	193,265 $12.8 Million
Q4 2021 Feb 07, 2022	SELL	$54.02 - $63.83 $894,355 - $1.06 Million	-16,556 Reduced 7.47%	205,199 $12 Million
Q3 2021 Oct 28, 2021	BUY	$55.56 - $60.79 $1.15 Million - $1.26 Million	20,777 Added 10.34%	221,755 $13.3 Million
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $38,251 - $47,542	-790 Reduced 0.39%	200,978 $12 Million
Q1 2021 May 06, 2021	SELL	$47.16 - $54.44 $1.07 Million - $1.23 Million	-22,683 Reduced 10.11%	201,768 $10 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $833,088 - $996,203	-17,170 Reduced 7.11%	224,451 $11.2 Million
Q3 2020 Nov 06, 2020	SELL	$53.07 - $61.1 $580,904 - $668,800	-10,946 Reduced 4.33%	241,621 $13.2 Million
Q2 2020 Jul 29, 2020	SELL	$43.1 - $55.31 $559,567 - $718,089	-12,983 Reduced 4.89%	252,567 $13.4 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $704,670 - $957,150	18,647 Added 7.55%	265,550 $11.9 Million
Q4 2019 Feb 07, 2020	SELL	$42.46 - $50.46 $150,478 - $178,830	-3,544 Reduced 1.42%	246,903 $12.3 Million
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $210,509 - $238,581	-5,247 Reduced 2.05%	250,447 $11.2 Million
Q2 2019 Aug 12, 2019	SELL	$37.28 - $41.68 $27,028 - $30,218	-725 Reduced 0.28%	255,694 $10.6 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $863,294 - $1.05 Million	-24,325 Reduced 8.66%	256,419 $10.4 Million
Q4 2018 Feb 01, 2019	SELL	$36.86 - $41.49 $700,819 - $788,849	-19,013 Reduced 6.34%	280,744 $10.7 Million
Q3 2018 Nov 09, 2018	BUY	$34.76 - $39.72 $23,358 - $26,691	672 Added 0.22%	299,757 $11.9 Million
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $249,589 - $267,649	-7,224 Reduced 2.36%	299,085 $10.5 Million
Q1 2018 May 04, 2018	SELL	$32.97 - $36.63 $356,405 - $395,970	-10,810 Reduced 3.41%	306,309 $10.7 Million
Q4 2017 Feb 06, 2018	BUY	$32.09 - $34.78 $53,782 - $58,291	1,676 Added 0.53%	317,119 $11 Million
Q3 2017 Nov 13, 2017	SELL	$28.96 - $34.0 $90,586 - $106,352	-3,128 Reduced 0.98%	315,443 $10.7 Million
Q2 2017 Aug 11, 2017	BUY	N/A	318,571	318,571 $10.9 Million

Others Institutions Holding AZN

# of Institutions

1,333

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account